Back to search

France· FR:68296666

DOPRAM 2 POUR CENT, solution injectable

A doxapram product containing chlorhydrate de doxapram, registered in France by EFISCIENS (MALTE). The same ATC class is registered in 9 of our 19 countries.

ATC R07AB01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDOPRAM 2 POUR CENT, solution injectab…ATCR07AB01REGISTER NO.FR:68296666PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Doxapram is registered in 9 of 19 countries.

Countries holding a registration under ATC R07AB01 (doxapram), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Doxapram · ATC R07AB01

9 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE DOXAPRAM
Manufacturer
EFISCIENS (MALTE)
Country
France (FR)
ATC code
R07AB01
ATC class
Doxapram
Defined daily dose
0.4 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400955095248
    50 ampoule(s) en verre de 3 ml
  • cip13
    3400956071784
    1 flacon(s) en verre de 20 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

66 interactions on record for doxapram.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxapram · interactions on record

66 records

  • 20 severe
  • 46 moderate

Most severe, free to view

  • LinezolidJ01XX08severe
  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxapram in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxapram products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Belgium · Dopram
  • Germany · Dopram
  • United Kingdom (Northern Ireland) · Dopram, Doxapram Hydrochloride Mercury Pharmaceuticals Limited
  • Ireland · Doxapram Hydrochloride Mercurypharm Ltd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2387df74-e01a-49a1-b0ed-1aea59e3f050
GET /v1/drugs/2387df74-e01a-49a1-b0ed-1aea59e3f050?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68296666",
  "date_amm": "1997-12-08",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE DOXAPRAM",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about doxapram.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.